- News Home
5 December 2013 11:26 am ,
Vol. 342 ,
Snake venoms are remarkably complex mixtures that can stun or kill prey within minutes. But more and more researchers...
At age 30, Dutch biologist Freek Vonk has built up a respectable career as a snake scientist. But in his home country,...
Since arriving on the island of Guam in the 1940s, the brown tree snake ( Boiga irregularis ) has extirpated native...
An animal rights group known as the Nonhuman Rights Project filed lawsuits in three New York courts this week in an...
Researchers have been hot on the trail of the elusive Denisovans, a type of ancient human known only by their DNA and...
Thousands of scientists in the Russian Academy of Sciences (RAS) are about to lose their jobs as a result of the...
Dyslexia, a learning disability that hinders reading, hasn't been associated with deficits in vision, hearing, or...
Exotic, elusive, and dangerous, snakes have fascinated humankind for millennia. They can be hard to find, yet their...
- 5 December 2013 11:26 am , Vol. 342 , #6163
- About Us
Small Business Research Program Gets 2-Month Lifeline
4 August 2009 10:59 am
A $2.5 billion-a-year program to fund research by small businesses received a 2-month extension last week. The move gives the U.S. Congress more time to reconcile differences in how to revamp the Small Business Innovation Research (SBIR) and the Small Business Technology Transfer (STTR) programs, which would have expired on 31 July without the extension.
The Senate and the House of Representatives have passed different versions of a bill to reauthorize the programs, which are funded by taxing the research budgets of 11 federal agencies. The Senate wants to grow the overall size of the program by raising the SBIR allocation from 2.5% to 3.5% over 10 years and the STTR allocation from 0.3% to 0.6%, while the House would like to see larger individual grants—up to $2 million for Phase II from the current ceiling of $750,000. The two houses also differ in how they would fix a 2002 ruling that limits participation by companies owned by venture capitalists. The Senate would reauthorize the programs until 2023, while the House bill would cover only 2 years.